Ngm Biopharmaceuticals Inc

NGMCIK 0001426332 · Every Form 4 filed by insiders at this issuer. See financials →

Annual report (10-K)

Latest 10-K/A filed Apr 4, 2024. Sentiment + YoY language diff vs prior year. Read sections →

Signal:NeutralFull-doc fallback

Full filing:tone 0.0007

Sentiment via Loughran-McDonald lexicon · YoY diff via Jaccard similarity + paragraph set difference.

Recent 8-K announcements

Per-item disclosure feed. Item 2.02 is the earnings release.

Apr 5, 2024no items parsed Mar 11, 2024no items parsed Feb 26, 2024no items parsed Jan 22, 2024no items parsed Jan 2, 2024no items parsed

YoY shift: Unscored

Year-over-year tone shift - average net-tone change across Risk Factors and MD&A vs the prior 10-K.

Why YoY instead of absolute: the LM lexicon has ~6.6× more negative words than positive (legal/risk-disclosure language is heavy on hedging), so every 10-K reads bearish on raw tone. Year-over-year change strips that bias and surfaces the actual shift in management's framing.

Per-snippet highlights

Sentence-level sentiment highlighting with category and subcategory filters is coming once the snippet-scoring pipeline lands. For now, dig into the actual section text on the Sections tab.

Top insiders

Most active reporters at Ngm Biopharmaceuticals Inc

Name	Roles	Filings
Column Group L P	Director10% Owner	41
Goeddel David V	Director10% Owner	20
Column Group Gp, LP	10% Owner	18
Column Group II, LP	10% Owner	18
Column Group III, LP	10% Owner	18

Showing 1-5 of 34

Per pagePage 1 of 7Next

All filings

103 Form 4 / 4-A filings, newest first

Filed	Insider	Top transaction	Shares	Price	Value
Apr 8, 2024	Goeddel David V Director · 10% Owner	DDisposition	134,180	-	-
Apr 8, 2024	Column Group L P Director · 10% Owner	DDisposition	949,862	-	-
Apr 8, 2024	Column Group Gp, LP 10% Owner	DDisposition	949,862	-	-
Apr 8, 2024	Tcg Opportunity III Gp, LLC 10% Owner	DDisposition	949,862	-	-
Apr 8, 2024	Lieu Hsiao D Chief Medical Officer	UTender	19,349	-	-

Showing 1-5 of 103

Per pagePage 1 of 21Next

Real-time Form 4 intelligence. Smarter insider tracking.

Filed		Top transaction	Shares	Price	Value